HomeANEB • NASDAQ
add
Anebulo Pharmaceuticals Inc
Previous close
$0.43
Day range
$0.43 - $0.45
Year range
$0.43 - $3.42
Market cap
18.04M USD
Avg Volume
88.57K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 2.62M | 1.23% |
Net income | -2.00M | 18.82% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 9.04M | -39.72% |
Total assets | 9.42M | -40.52% |
Total liabilities | 1.49M | 69.05% |
Total equity | 7.94M | — |
Shares outstanding | 40.78M | — |
Price to book | 2.29 | — |
Return on assets | -65.10% | — |
Return on capital | -74.12% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -2.00M | 18.82% |
Cash from operations | -1.31M | 6.58% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | -1.31M | -109.66% |
Free cash flow | -962.15K | -71.81% |
About
Founded
2020
Headquarters
Website
Employees
3
